Ampio Pharmaceuticals Stock Forecast, Price & News

-0.01 (-0.64 %)
(As of 04/20/2021 12:50 PM ET)
Today's Range
Now: $1.56
50-Day Range
MA: $1.77
52-Week Range
Now: $1.56
Volume19,171 shs
Average Volume3.40 million shs
Market Capitalization$305.18 million
P/E RatioN/A
Dividend YieldN/A
Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.
Ampio Pharmaceuticals logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Phone(720) 437-6500
Year FoundedN/A



Sales & Book Value

Annual SalesN/A
Book Value$0.04 per share


Net Income$-13,630,000.00


Market Cap$305.18 million
Next Earnings Date5/5/2021 (Estimated)


AMPE Apr 2021 1.500 call
March 22, 2021 |  ca.finance.yahoo.com
AMPE Apr 2021 0.500 call
March 22, 2021 |  ca.finance.yahoo.com
Why Ampio Pharmaceuticals Stock Is Jumping Today
March 4, 2021 |  finance.yahoo.com
Ampio Pharmaceuticals, Inc. to Host Earnings Call
March 3, 2021 |  finance.yahoo.com
AMPE Jul 2021 2.500 call
February 7, 2021 |  uk.finance.yahoo.com
AMPE Jul 2021 0.500 call
February 7, 2021 |  uk.finance.yahoo.com
See More Headlines


Overall MarketRank

1.33 out of 5 stars

Medical Sector

772nd out of 2,018 stocks

Pharmaceutical Preparations Industry

371st out of 772 stocks

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
-0.01 (-0.64 %)
(As of 04/20/2021 12:50 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AMPE News and Ratings via Email

Sign-up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Frequently Asked Questions

Is Ampio Pharmaceuticals a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ampio Pharmaceuticals in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Ampio Pharmaceuticals stock.
View analyst ratings for Ampio Pharmaceuticals
or view top-rated stocks.

What stocks does MarketBeat like better than Ampio Pharmaceuticals?

Wall Street analysts have given Ampio Pharmaceuticals a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Ampio Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Ampio Pharmaceuticals' next earnings date?

Ampio Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Ampio Pharmaceuticals

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE) issued its quarterly earnings data on Tuesday, March, 2nd. The specialty pharmaceutical company reported ($0.02) EPS for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.02).
View Ampio Pharmaceuticals' earnings history

How has Ampio Pharmaceuticals' stock been impacted by COVID-19?

Ampio Pharmaceuticals' stock was trading at $0.5307 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, AMPE stock has increased by 190.2% and is now trading at $1.54.
View which stocks have been most impacted by COVID-19

What price target have analysts set for AMPE?

1 brokers have issued twelve-month price targets for Ampio Pharmaceuticals' stock. Their forecasts range from $4.00 to $4.00. On average, they anticipate Ampio Pharmaceuticals' stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 159.7% from the stock's current price.
View analysts' price targets for Ampio Pharmaceuticals
or view top-rated stocks among Wall Street analysts.

Who are Ampio Pharmaceuticals' key executives?

Ampio Pharmaceuticals' management team includes the following people:
  • Michael E. Macaluso, Chairman & Chief Executive Officer
  • Holli Cherevka, Chief Operating Officer
  • Daniel G. Stokely, Chief Financial Officer, Secretary & Treasurer

Who are some of Ampio Pharmaceuticals' key competitors?

What other stocks do shareholders of Ampio Pharmaceuticals own?

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "AMPE."

Who are Ampio Pharmaceuticals' major shareholders?

Ampio Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Chicago Capital LLC (0.06%) and HighPoint Advisor Group LLC (0.01%).
View institutional ownership trends for Ampio Pharmaceuticals

Which institutional investors are selling Ampio Pharmaceuticals stock?

AMPE stock was sold by a variety of institutional investors in the last quarter, including HighPoint Advisor Group LLC.
View insider buying and selling activity for Ampio Pharmaceuticals
or view top insider-selling stocks.

Which institutional investors are buying Ampio Pharmaceuticals stock?

AMPE stock was acquired by a variety of institutional investors in the last quarter, including Chicago Capital LLC.
View insider buying and selling activity for Ampio Pharmaceuticals
or or view top insider-buying stocks.

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $1.54.

How much money does Ampio Pharmaceuticals make?

Ampio Pharmaceuticals has a market capitalization of $301.27 million. The specialty pharmaceutical company earns $-13,630,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis.

How many employees does Ampio Pharmaceuticals have?

Ampio Pharmaceuticals employs 23 workers across the globe.

What is Ampio Pharmaceuticals' official website?

The official website for Ampio Pharmaceuticals is ampiopharma.com.

Where are Ampio Pharmaceuticals' headquarters?

Ampio Pharmaceuticals is headquartered at 373 Inverness Pkwy Ste 200, ENGLEWOOD, CO 80112-5898, United States.

How can I contact Ampio Pharmaceuticals?

Ampio Pharmaceuticals' mailing address is 373 Inverness Pkwy Ste 200, ENGLEWOOD, CO 80112-5898, United States. The specialty pharmaceutical company can be reached via phone at (720) 437-6500.

This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.